Taken together, these findings suggest that disruption of circadian regulation of ANGPTL2 expression leads to chronic inflammation, resulting in development of lifestyle-related metabolic disorders and cardiovascular disease. This evidence concerns the gene ANGPTL2 and Other metabolic disease.